Patents by Inventor Janice Lau Wee

Janice Lau Wee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230143841
    Abstract: Provided are non-natural or variant ?-ketoacyl-acyl carrier protein (ACP) synthase (KAS) IVa enzymes (KASIVa), polynucleotides encoding such variant KASIVa, host cells expressing such variant KASIVa, oils and oil products produced by such cells, and methods of making and using such variant KASIVa.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 11, 2023
    Inventors: Joshua FERREIRA, Janice Lau WEE, Nien-Hsi KO
  • Patent number: 11618890
    Abstract: Provided are non-natural or variant beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS) II enzymes (KASII), polynucleotides encoding such variant KASII, host cells expressing such variant KASII, oils and oil products produced by such cells, and methods of making and using such variant KASII.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: April 4, 2023
    Assignee: Corbion Biotech, Inc.
    Inventors: Nien-Hsi Ko, Joshua Ferreira, Janice Lau Wee, William E. Maffe, Douglas A. Hattendorf
  • Publication number: 20230037413
    Abstract: The present disclosure provides sucrose invertase variants having an enhanced ability to hydrolyze sucrose into glucose and fructose and related methods and compositions.
    Type: Application
    Filed: November 19, 2020
    Publication date: February 9, 2023
    Applicant: Corbion Biotech, Inc.
    Inventors: Nien-Hsi KO, Janice Lau WEE, Douglas A. HATTENDORF
  • Patent number: 11352602
    Abstract: The present invention provides methods for making microalgal strains with improved properties relative to the strains from which they are derived. In illustrative embodiments, the methods are performed to produce microalgal strains adapted for use in the industrial production of microalgae-derived biomass products, including but not limited to triglycerides and fatty acids. Also provided are microalgal strains, which can be obtained using the methods described herein, as wells microalgal-derived biomass products, which can be produced from such microalgal strains.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: June 7, 2022
    Assignee: Corbion Biotech, Inc.
    Inventors: Janice Lau Wee, Dawei Yuan, Wenhua Lu, Rika Regentin, Jeffrey Villari
  • Publication number: 20210246434
    Abstract: Provided are non-natural or variant beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS) II enzymes (KASII), polynucleotides encoding such variant KASII, host cells expressing such variant KASII, oils and oil products produced by such cells, and methods of making and using such variant KASII.
    Type: Application
    Filed: August 21, 2019
    Publication date: August 12, 2021
    Inventors: Nien-Hsi KO, Joshua FERREIRA, Janice Lau WEE, William E. MAFFE, Douglas A. HATTENDORF
  • Publication number: 20180163170
    Abstract: The present invention provides methods for making microalgal strains with improved properties relative to the strains from which they are derived. In illustrative embodiments, the methods are performed to produce microalgal strains adapted for use in the industrial production of microalgae-derived biomass products, including but not limited to triglycerides and fatty acids. Also provided are microalgal strains, which can be obtained using the methods described herein, as wells microalgal-derived biomass products, which can be produced from such microalgal strains.
    Type: Application
    Filed: March 30, 2016
    Publication date: June 14, 2018
    Applicant: TERRAVIA HOLDINGS, INC.
    Inventors: Janice Lau WEE, Dawei YUAN, Wenhua LU, Rika REGENTIN, Jeffrey VILLARI
  • Patent number: 7855192
    Abstract: Macrolactams are made by feeding aromatic amino acids as replacement starter units to a mutant strain of the geldanamycin-producing microorganism Streptomyces hygroscopicus var. geldanus NRRL 3602, wherein the gene cluster encoding enzymes for the biosynthesis of the natural starter unit 3-amino-5-hydroxybenzoic acid has been deleted.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: December 21, 2010
    Assignee: Kosan Biosciences, Inc.
    Inventors: Gary W. Ashley, Hugo Menzella, Janice Lau Wee, John R. Carney
  • Publication number: 20080188450
    Abstract: Macrolactams are made by feeding aromatic amino acids as replacement starter units to a mutant strain of the geldanamycin-producing microorganism Streptomyces hygroscopicus var. geldanus NRRL 3602, wherein the gene cluster encoding enzymes for the biosynthesis of the natural starter unit 3-amino-5-hydroxybenzoic acid has been deleted.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 7, 2008
    Inventors: Gary W. Ashley, Hugo Menzella, Janice Lau Wee, John R. Carney